Cetera Trust Company’s GSK GSK Stock Holding History

Cetera Trust Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$414K	Buy	7,905 +60	+0.8%	+$3.17K	0.21%	90
2026 Q1	$433K	Hold	7,845	–	–	0.24%	80
2025 Q4	$385K	Buy	7,845 +450	+6%	+$21K	0.21%	85
2025 Q3	$319K	Buy	7,395 +400	+6%	+$15.6K	0.18%	104
2025 Q2	$269K	Buy	6,995 +375	+6%	+$14.3K	0.16%	126
2025 Q1	$256K	Buy	6,620 +30	+0.5%	+$1.1K	0.16%	124
2024 Q4	$223K	Buy	6,590 +485	+8%	+$17.5K	0.14%	156
2024 Q3	$250K	Hold	6,105	–	–	0.15%	137
2024 Q2	$235K	Hold	6,105	–	–	0.15%	134
2024 Q1	$262K	Sell	6,105 -160	-3%	-$6.6K	0.16%	121
2023 Q4	$232K	Buy	+6,265	New	+$225K	0.14%	133

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cetera Trust Company's GSK Position: Q2 2026 in Review

Cetera Trust Company increased its GSK (GSK) stake by 0.76% in Q2 2026, buying an estimated $3.17K and bringing the position to 7,905 shares worth $414K. The position accounts for 0.21% of the portfolio, ranked #90.

Cetera Trust Company first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $433K in Q1 2026. 1,041 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Cetera Trust Company held 7,905 shares of GSK worth $414K as of Q2 2026.
Cetera Trust Company bought 60 GSK shares in Q2 2026, an estimated $3.17K.
GSK made up 0.21% of Cetera Trust Company's portfolio in Q2 2026, its #90 holding.
Cetera Trust Company first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
Cetera Trust Company's GSK position peaked at $433K in Q1 2026.
1,041 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.